Furthermore, studies are required to verify whether treatment with glucocorticoids or immunosuppressive agents might exert their therapeutic effect on SLE patients by inhibiting the overexpression of GITR and GITRL proteins. Here, TNFRSF18 is linked to systemic lupus erythematosus.